Eisai Company Ltd (OP: ESALF )
55.05 UNCHANGED Streaming Delayed Price Updated: 10:35 AM EDT, Mar 22, 2023 Add to My Watchlist
All News about Eisai Company Ltd
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
August 03, 2022
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
Biogen's Potential Early Alzheimer's Treatment Sees Second Death Linked To It, Shares Fall
November 28, 2022
A 65-year-old woman with early Alzheimer's disease receiving Biogen Inc's (NASDAQ: BIIB) antibody lecanemab treatment to slow the cognitive decline recently died from a massive brain hemorrhage that...
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following